However, WNK1-induced Smad2 phosphorylation at residue Ser-465 interferes with the TGF-β-induced phosphorylation, nuclear translocation and transcriptional activity of Smad2, thereby inhibiting TGF-β signal transduction in cancer cells [88]. This evidence concerns the gene SMAD2 and cancer.